- ICH GCP
- 미국 임상 시험 레지스트리
- 임상시험 NCT05192083
A Pilot Trial of a Smartphone-based Self-management Support Program for COPD Patients
A Pilot Trial of a Smartphone-based Self-management Support Program for Patients With Chronic Obstructive Pulmonary Disease
COPD patients often experience multiple symptoms (e.g. dyspnea, cough, and deteriorating quality of life) and have imposed a substantial economic and social burden on health care.
The current proposal is to evaluate the feasibility and acceptability of a pilot trial of a smartphone-based instant messaging self-management support program to improve the quality of life in patients with COPD.
연구 개요
상세 설명
Chronic obstructive pulmonary disease (COPD) is the number 3 killer globally by 2020. COPD patients often experience multiple symptoms (e.g. dyspnea, cough, and deteriorating quality of life) and have imposed a substantial economic and social burden on health care.
Current policy for the prevention and management of long-term conditions focuses on efforts to prevent the onset or slow progression of disease early in the disease trajectory. This prevention paradigm has only recently been adopted for COPD. Systematic reviews have shown self-management support for patients with COPD is effective in improving health-related quality of life and in reducing hospital admissions, but the evidence comes largely from patients with moderate or severe disease and is predominantly recruited from secondary care. Simple and systematic strategies are needed to improve out-of-hospital support and management for people living with COPD.
An instant messaging smartphone app, which allows texts, audio, pictures and video messages to be shared in chat groups, is already available to and is the most popular in the Hong Kong general public. Mobile instant messaging can be conducted through a daily use device to increase access and efficacy, which has been suggested as a feasible approach to delivering an intervention with positive effects on health behaviours and outcomes. Text messaging via mobile phones has been shown to be effective in helping promote lifestyle change in diabetes self-management, weight loss, physical activity, smoking cessation and medication adherence with quantitative and qualitative evidence. However, the investigator has not found messaging intervention that was applied in people with COPD, except an ongoing study of using instant text message support for patients with chronic respiratory and cardiovascular diseases.
Hence, the current intervention program is to evaluate the feasibility and acceptability of a smartphone-based instant messaging self-management support program to improve the quality of life in patients with COPD.
연구 유형
등록 (예상)
단계
- 해당 없음
연락처 및 위치
연구 연락처
- 이름: Asa Choi, MA
- 전화번호: 852-3917-6563
- 이메일: asachoi@hku.hk
연구 연락처 백업
- 이름: Agnes YK Lai, PhD
- 전화번호: 852-3917-6328
- 이메일: agneslai@hku.hk
연구 장소
-
-
-
Hong Kong, 홍콩, 852
- 모병
- Queen Mary Hospital
-
연락하다:
- David Lam, PhD
- 전화번호: 2255-4455
- 이메일: slnga@hku.hk
-
연락하다:
- Agnes Lai, PhD
- 전화번호: 93176779
- 이메일: agneslai@hku.hk
-
-
참여기준
자격 기준
공부할 수 있는 나이
건강한 자원 봉사자를 받아들입니다
연구 대상 성별
설명
Inclusion criteria
- Aged 18 years and above
- Diagnosis with COPD
- General condition stable
- Able to speak and read Chinese
- Able to complete the self-administered questionnaire
- Able to use instant messages such as WhatsApp or WeChat
- Mental, cognitive and physically fit for joining the trial as determined by the clinician or responsible investigator
- Signed informed consent
Exclusion criteria
- Skeletal fragility
- Serious active infection
- Inability to walk
- Severe respiratory insufficiency
공부 계획
연구는 어떻게 설계됩니까?
디자인 세부사항
- 주 목적: 지지 요법
- 할당: 해당 없음
- 중재 모델: 단일 그룹 할당
- 마스킹: 없음(오픈 라벨)
무기와 개입
참가자 그룹 / 팔 |
개입 / 치료 |
---|---|
실험적: Intervention group
The intervention group will receive a smartphone-based self-management support programme, including a 30-min face-to-face or online session at baseline, 3 phone calls (week 2, week 4 and week 6) and 2-month mobile messages in addition to usual care.
|
A smartphone-based self-management support programme includes a 30-min face-to-face or online session at baseline, 3 phone calls and 2-month mobile messages
|
연구는 무엇을 측정합니까?
주요 결과 측정
결과 측정 |
측정값 설명 |
기간 |
---|---|---|
Change from baseline COPD-related quality of life
기간: Baseline, Week 8
|
COPD symptoms and impacts and activity level were measured by an 8-item COPD Assessment Test.
Total scores range from 0 to 40, with higher scores denoting a more severe impact of COPD on a patient's life.
|
Baseline, Week 8
|
2차 결과 측정
결과 측정 |
측정값 설명 |
기간 |
---|---|---|
Change from baseline patient activation
기간: Baseline, Week 8
|
Knowledge, skills and confidence in self-management were measured by a 13-item Patient Activation Measure Scale.
The total score ranges from 0 (no activation) to 100 (high activation), with higher scores denoting the better patient activation.
|
Baseline, Week 8
|
Change from baseline self-efficacy for self-management
기간: Baseline, Week 8
|
Confidence and perceived ability of self-care were measured by a 6-item Stanford self-efficacy scale.
The score for each item ranges from 1 (not at all confident) to 10 (totally confident).
The total score of the scale is the mean of the six items, with higher number indicates higher self-efficacy.
|
Baseline, Week 8
|
Change from baseline acceptance of illness
기간: Baseline, Week 8
|
Acceptance of illness measured by a 8-item acceptance of illness scale.
Each item ranges from 1 to 5. The total score of the scale is between 8 and 40, with low score showing a lack of adjustment to the disease, no acceptance of the condition, and mental discomfort, while high score indicating good disease acceptance.
|
Baseline, Week 8
|
Change from baseline medication adherence
기간: Baseline, Week 8
|
Medication adherence measured by a 4-item Morisky Medication-Taking Adherence Scale.
The scale consists of four items with a scoring scheme of "Yes" = 0 and "No" = 1.
All items are summed to give a range of scores from 0 to 4, with higher score indicating a low level of medication adherence.
|
Baseline, Week 8
|
Change from baseline physical activity level
기간: Baseline, Week 8
|
Physical activity measured by a 7-item International Physical Activity Questionnaire-short form.
Number of days and duration (in hours and minutes) engaging in vigorous activities, moderate activities, and walking in past 7 days will be collected.
Duration (in hours and minutes) of sitting time on week days and weekends will be collected.
|
Baseline, Week 8
|
Change from dyspnea severity
기간: Baseline, week 8
|
Dyspnea severity measured by a 1-item MRC dyspnea scale.
The scale consists of five statements about perceived breathlessness: grade 1, "I only get breathless with strenuous exercise"; grade 2, "I get short of breath when hurrying on the level or up a slight hill"; grade 3, "I walk slower than people of the same age on the level because of breathlessness or have to stop for breath when walking at my own pace on the level"; grade 4, "I stop for breath after walking 100 yards or after a few minutes on the level"; grade 5, " I am too breathless to leave the house".
Patients selected the grade that applied to them.
|
Baseline, week 8
|
Change from baseline Health status
기간: Baseline, Week 8
|
Health status measured by a 5-item EuroQol 5-Dimension questionnaire.
The scale comprises five dimensions: mobility, self-care, usual activities, pain/discomfort and anxiety/depression.
Each dimension was scored by five levels, with 1 representing no problem and 5 representing extreme problem.
|
Baseline, Week 8
|
Change from anxiety and depressive symptoms
기간: Baseline, Week 8
|
Anxiety and depressive symptoms measured by a 14-item Hospital Anxiety and Depression Scale.
Each item ranges from 0-3.
The total scores of both Anxiety and Depression subscales range from 0-21, with higher scores indicating higher level of anxiety and depression respectively.
|
Baseline, Week 8
|
Change in baseline social support
기간: Baseline, Week 8
|
Social support measured by a 6-item Multidimensional Scale of Perceived Social Support.
Each item ranges from 1 (very strongly disagree) to 7 (very strongly agree).
The total score is the sum across all items divided by 6, with higher score indicating more social support.
|
Baseline, Week 8
|
Change in from baseline sleep quality
기간: Baseline, Week 8
|
Sleep quality measured by a 7-item Insomnia Severity Index.
The total score range from 0 (absence of insomnia) to 28 (severe insomnia).
|
Baseline, Week 8
|
Change in baseline grip strength
기간: Baseline, Week 8
|
Grip strength of both hands measured by dynamometer
|
Baseline, Week 8
|
Change in baseline balance
기간: Baseline, Week 8
|
Balance assessed by a single-leg stance test.
|
Baseline, Week 8
|
공동 작업자 및 조사자
간행물 및 유용한 링크
일반 간행물
- Hall AK, Cole-Lewis H, Bernhardt JM. Mobile text messaging for health: a systematic review of reviews. Annu Rev Public Health. 2015 Mar 18;36:393-415. doi: 10.1146/annurev-publhealth-031914-122855.
- Buttery SC, Zysman M, Vikjord SAA, Hopkinson NS, Jenkins C, Vanfleteren LEGW. Contemporary perspectives in COPD: Patient burden, the role of gender and trajectories of multimorbidity. Respirology. 2021 May;26(5):419-441. doi: 10.1111/resp.14032. Epub 2021 Mar 9.
- Jolly K, Sidhu MS, Hewitt CA, Coventry PA, Daley A, Jordan R, Heneghan C, Singh S, Ives N, Adab P, Jowett S, Varghese J, Nunan D, Ahmed K, Dowson L, Fitzmaurice D. Self management of patients with mild COPD in primary care: randomised controlled trial. BMJ. 2018 Jun 13;361:k2241. doi: 10.1136/bmj.k2241.
- Redfern J, Hyun K, Singleton A, Hafiz N, Raeside R, Spencer L, Carr B, Caterson I, Cullen J, Ferry C, Santo K, Hayes A, Leung RWM, Raadsma S, Swinbourne J, Cho JG, King M, Roberts M, Kok C, Jenkins C, Chow C. ITM support for patients with chronic respiratory and cardiovascular diseases: a protocol for a randomised controlled trial. BMJ Open. 2019 Mar 1;9(3):e023863. doi: 10.1136/bmjopen-2018-023863.
유용한 링크
연구 기록 날짜
연구 주요 날짜
연구 시작 (실제)
기본 완료 (예상)
연구 완료 (예상)
연구 등록 날짜
최초 제출
QC 기준을 충족하는 최초 제출
처음 게시됨 (실제)
연구 기록 업데이트
마지막 업데이트 게시됨 (실제)
QC 기준을 충족하는 마지막 업데이트 제출
마지막으로 확인됨
추가 정보
이 연구와 관련된 용어
개별 참가자 데이터(IPD) 계획
개별 참가자 데이터(IPD)를 공유할 계획입니까?
IPD 계획 설명
IPD 공유 기간
IPD 공유 액세스 기준
IPD 공유 지원 정보 유형
- 연구_프로토콜
약물 및 장치 정보, 연구 문서
미국 FDA 규제 의약품 연구
미국 FDA 규제 기기 제품 연구
이 정보는 변경 없이 clinicaltrials.gov 웹사이트에서 직접 가져온 것입니다. 귀하의 연구 세부 정보를 변경, 제거 또는 업데이트하도록 요청하는 경우 register@clinicaltrials.gov. 문의하십시오. 변경 사항이 clinicaltrials.gov에 구현되는 즉시 저희 웹사이트에도 자동으로 업데이트됩니다. .
Self-management and Support에 대한 임상 시험
-
Dartmouth-Hitchcock Medical CenterCenters for Disease Control and Prevention완전한
-
Dartmouth-Hitchcock Medical CenterCenters for Disease Control and Prevention모병
-
University of OregonSpecial X Inc.모병부모-자녀 관계 | 육아 | 아동 행동 | 발달 장애 | 개발 지연 | 발달 장애, 아동미국
-
Oregon Health and Science University아직 모집하지 않음상처와 부상 | 통증 관리 | 인간 공학